NovaBay Pharmaceuticals (NBY) Posts Break Even Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Other income (expense), net: -52K
Today's EPS Names:
SFBC, KSBI, PVBK, More
Financial Fact:
Other income (expense), net: -52K
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $3.64 million versus the consensus estimate of $3.08 million.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Pacific Valley Bank (PVBK) Tops Q3 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
